Liminatus Pharma, Inc.

Nasdaq:LIMNNasdaq:LIMNW

Biological Products, (No Diagnostic Substances)·CERRITOS, CA

Financials

3 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	10/6/25	→
10-Q	Q1 2025	3/31/25	6/2/25	→

News (8-K)

15 shown

Filed	Type	Description
3/4/26	Other	Amendments to Articles of Incorporation or Bylaws	→
2/18/26	Agreement	Entry into a Material Definitive Agreement	→
2/9/26	Agreement	Entry into a Material Definitive Agreement	→
1/26/26	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
11/25/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
8/25/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
↓

Prospectuses & Registrations

13 shown

Filed	Form	Description
2/18/26	424B4	424B4	→
2/11/26	S-1	S-1	→
8/13/25	424B3	424B3	→
7/28/25	S-1/A	S-1/A	→
6/24/25	S-1	S-1	→
2/7/25	424B3	424B3	→
↓

Filing History(82 filings)

TypeDateAccessionPeriodSize

8-K

Mar 4, 2026

0001104659-26-023467FORM 8-K

Feb 27, 2026

407.1 KB

SCHEDULE 13G

Feb 20, 2026

0001213900-26-018820

—

16.6 KB

8-K

Feb 18, 2026

0001104659-26-017134FORM 8-K

Feb 17, 2026

920.0 KB

424B4

Feb 18, 2026

0001104659-26-016706424B4

—

2.4 MB

EFFECT

Feb 13, 2026

9999999995-26-000587

—

1.8 KB

S-1

Feb 11, 2026

0001104659-26-012942S-1

—

13.7 MB

8-K

Feb 9, 2026

0001104659-26-012016FORM 8-K

Feb 6, 2026

235.0 KB

8-K

Jan 26, 2026

0001104659-26-006619FORM 8-K

Jan 15, 2026

235.5 KB

DRS

Dec 31, 2025

0001104659-25-125670

—

2.6 MB

8-K

Nov 25, 2025

0001104659-25-116049FORM 8-K

Nov 19, 2025

237.9 KB

10-Q

Nov 14, 2025

0001104659-25-11165110-Q

Sep 30, 2025

5.6 MB

10-Q

Oct 6, 2025

0001104659-25-09687210-Q

Jun 30, 2025

5.8 MB

8-K

Aug 25, 2025

0001104659-25-082579FORM 8-K

Aug 22, 2025

245.3 KB

Aug 15, 2025

0001200876-25-000042PRIMARY DOCUMENT

Apr 30, 2025

4.0 KB

NT 10-Q

Aug 15, 2025

0001104659-25-078852NT 10-Q

Jun 30, 2025

23.3 KB

8-K

Aug 14, 2025

0001104659-25-078577FORM 8-K

Aug 14, 2025

244.4 KB

424B3

Aug 13, 2025

0001410578-25-001746424B3

—

4.4 MB

EFFECT

Aug 12, 2025

9999999995-25-002576

—

1.8 KB

CORRESP

Aug 11, 2025

0001104659-25-076067

—

5.9 KB

S-1/A

Jul 28, 2025

0001410578-25-001518S-1/A

—

25.6 MB

CORRESP

Jul 25, 2025

0001104659-25-070940

—

16.4 KB

Jul 23, 2025

0001104659-25-069941OWNERSHIP DOCUMENT

Jul 10, 2025

3.0 KB

Jul 21, 2025

0001104659-25-069332OWNERSHIP DOCUMENT

Jul 10, 2025

3.0 KB

8-K

Jul 17, 2025

0001104659-25-068670FORM 8-K

Jul 16, 2025

232.2 KB

8-K

Jul 11, 2025

0001104659-25-067444FORM 8-K

Jul 10, 2025

233.5 KB

25 filings shown

Liminatus Pharma, Inc.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(82 filings)

Ownership

Other Filings

Filed	Form	Description
8/15/25	3	PRIMARY DOCUMENT	→
7/23/25	3	OWNERSHIP DOCUMENT	→
7/21/25	3	OWNERSHIP DOCUMENT	→
6/27/25	3	INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	→
6/16/25	3	OWNERSHIP DOCUMENT	→
5/1/25	3	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
2/20/26	SCHEDULE 13G	SCHEDULE 13G	→
2/13/26	EFFECT	EFFECT	→
12/31/25	DRS	DRS	→
8/12/25	EFFECT	EFFECT	→
6/27/25	SCHEDULE 13G	SCHEDULE 13G	→
6/26/25	SCHEDULE 13G	SCHEDULE 13G	→
↓